P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING. (23rd June 2022)

• Record Type: Journal Article
• Authors: Schmidt, C.; Janssen, M.; Bruch, P.-M.; Blank, M. F.; Rohde, C.; Waclawiczek, A.; Renders, S.; Heid, D.; Göllner, S.; Vierbaum, L.; Weidenauer, K.; Herbst, S.; Knoll, M.; Kolb, C.; Besenbeck, B.; Fabre, M.; Gu, M.; Schlenk, R.; Stölzel, F.; Bornhäuser, M.; Röllig, C.; Platzbecker, U.; Baldus, C.; Serve, H.; Sauer, T.; Raffel, S.; Pabst, C.; Vassiliou, G.; Vick, B.; Jeremias, I.; Trumpp, A.; Krijgsveld, J.; Müller-Tidow, C.; Dietrich, S.;
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 354
• Page End: 355
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000844704.76170.f9
• Languages: English
• ISSNs: 2572-9241